Bacteriostatic antimicrobial combination: Antagonistic interaction between epsilon-viniferin and vancomycin against methicillin-resistant staphylococcus aureus

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Basri, Dayang Fredalina ^a   Xian, Lee Wee ^a   Abdul Shukor, Nur Indah ^a   Latip, Jalifah ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; JOHORENOL A; LINEZOLID; UNCLASSIFIED DRUG; VANCOMYCIN; VINIFERIN; BENZOFURAN DERIVATIVE; EPSILON-VINIFERIN; STILBENE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DRUG ANTAGONISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TREATMENT DURATION; APOPTOSIS; CELL SURVIVAL; DRUG COMBINATION; DRUG EFFECTS; DRUG INTERACTION; PHYSIOLOGY; PROCEDURES;

ANTI-INFECTIVE AGENTS; APOPTOSIS; BENZOFURANS; CELL SURVIVAL; DRUG ANTAGONISM; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STILBENES; VANCOMYCIN;

EID: 84899577766     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/461756     Document Type: Article

References (48)

1. Soriano A., Marco F., Martínez J. A., Pisos E., Almela M., Dimova V. P., Alamo D., Ortega M., Lopez J., Mensa J., Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clinical Infectious Diseases 2008 46 2 193 200 2-s2.0-39449112495 10.1086/524667 (Pubitemid 351269157)
2. Sakoulas G., Moise-Broder P. A., Schentag J., Forrest A., Moellering R. C. Jr., Eliopoulos G. M., Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. Journal of Clinical Microbiology 2004 42 6 2398 2402 2-s2.0-2942558870 10.1128/JCM.42.6.2398-2402.2004 (Pubitemid 38747480)
3. Lin G., Ednie L. M., Appelbaum P. C., Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay. Antimicrobial Agents and Chemotherapy 2010 54 5 2258 2261 2-s2.0-77951231541 10.1128/AAC.01350-09
4. Udobi C. E., Obajuluwa A. F., Onaolapo J. A., Prevalence and antibiotic resistance pattern of methicillin-resistant Staphylococcus aureus from an orthopaedic hospital in Nigeria. BioMed Research International 2013 2013 4 860467 10.1155/2013/860467
5. Rybak M. J., LaPlante K. L., Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005 25 1 74 85 2-s2.0-11144221727 10.1592/phco.25.1.74.55620 (Pubitemid 40054036)
6. Boucher H., Miller L. G., Razonable R. R., Serious infections caused by methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 2010 51 supplement 2 S183 S197 2-s2.0-77957868388 10.1086/653519
7. Hidayat L. K., Hsu D. I., Quist R., Shriner K. A., Wong-Beringer A., High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Archives of Internal Medicine 2006 166 19 2138 2144 2-s2.0-33750285524 10.1001/archinte.166.19.2138 (Pubitemid 44631403)
8. Bharti V., Vasudeva N., Duhan J. S., Bacteriostatic and fungistatic activities of Oreganum vulgare extract and volatile oil and interaction studies in combination with antibiotics and antifungal agents against food poisoning pathogens. International Food Research Journal 2013 20 3 1453 1458
9. Hemaiswarya S., Kruthiventi A. K., Doble M., Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008 15 8 639 652 2-s2.0-46049087489 10.1016/j.phymed.2008.06.008
10. Moss R., Mao Q., Taylor D., Saucier C., Investigation of monomeric and oligomeric wine stilbenoids in red wines by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 2013 30 1815 1827
11. Chong J., Poutaraud A., Hugueney P., Metabolism and roles of stilbenes in plants. Plant Science 2009 177 3 143 155 2-s2.0-67449103065 10.1016/j.plantsci.2009.05.012
12. Drago L., De Vecchi E., Nicola L., Gismondo M. R., In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infectious Diseases 2007 7, article 111 2-s2.0-35349017448 10.1186/1471-2334-7-111 (Pubitemid 47604308)
13. Belley A., Neesham-Grenon E., Arhin F. F., McKay G. A., Parr T. R. Jr., Moeck G., Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2008 52 10 3820 3822 2-s2.0-54049124669 10.1128/AAC.00361-08
14. Basri D. F., Khairon R., Pharmacodynamic interaction of Quercus infectoria galls extract in combination with vancomycin against MRSA using microdilution checkerboard and time-kill assay. Evidence-Based Complementary and Alternative Medicine 2012 2012 6 493156 10.1155/2012/493156
15. Basri D. F., Chan K. L., Azmi A. M., Jalifah L., Evaluation of the combined effects of stilbenoid from Shorea gibbosa and vancomycin against methicillin-resistant Staphylococcus aureus (MRSA). Pharmaceuticals 2012 5 1032 1043
16. Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard 2007 7th Wayne, Pa, USA
17. Drago L., De Vecchi E., Nicola L., Gismondo M. R., In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infectious Diseases 2007 7, article 111 2-s2.0-35349017448 10.1186/1471-2334-7-111 (Pubitemid 47604308)
18. Neu H. C., Gootz T. D., Baron S., Chapter 11: antimicrobial chemotherapy. Medical Microbiology 1996 4th Galveston, Tex, USA University of Texas Medical Branch at Galveston
19. Lee G. C., Burgess D. S., Polymyxins and doripenem combination against KPC-producing Klebsiella pneumoniae. Journal of Clinical Medicine Research 2013 5 2 97 100
20. Richard T., Pawlus A. D., Iglésias M.-L., Pedrot E., Waffo-Teguo P., Mérillon J.-M., Monti J.-P., Neuroprotective properties of resveratrol and derivatives. Annals of the New York Academy of Sciences 2011 1215 1 103 108 2-s2.0-78851468921 10.1111/j.1749-6632.2010.05865.x
21. Saiko P., Szakmary A., Jaeger W., Szekeres T., Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutation Research-Reviews in Mutation Research 2008 658 1-2 68 94 2-s2.0-38649132291 10.1016/j.mrrev.2007.08.004 (Pubitemid 351172881)
22. Sotheeswaran S., Pasupathy V., Distribution of resveratrol oligomers in plants. Phytochemistry 1993 32 5 1083 1092 2-s2.0-0001032917
23. Yim N., Ha D. T., Trung T. N., Kim J. P., Lee S., Na M., Jung H., Kim H. S., Kim Y. H., Bae K., The antimicrobial activity of compounds from the leaf and stem of Vitis amurensis against two oral pathogens. Bioorganic & Medicinal Chemistry Letters 2010 20 3 1165 1168 2-s2.0-74349104835 10.1016/j.bmcl.2009.12. 020
24. Asolini F. C., Tedesco A. M., Ferraz C., Alencar S. M., Carpes S. T., Antioxidant and antibacterial activities of phenolic compounds in extracts of plants used as tea. Brazilian Journal of Food Technology 2006 9 209 215
25. Eliopoulos G. M., Eliopoulos C. T., Abtibiotic combinations: should they be tested? Clinical Microbiology Reviews 1988 1 2 139 156 2-s2.0-0023823750
26. Rani A., Jain S., Dureja P., Kumar R., Kumar A., Synergistic interaction between synthetic and natural products: a promising tool for the development of environmentally safe potent antimicrobial agents. World Applied Sciences Journal 2009 5 59 63
27. Qin R., Xiao K., Li B., Jiang W., Peng W., Zheng J., Zhou H., The combination of catechin and epicatechin gallate from Fructus crataegi potentiates β -lactam antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo. International Journal of Molecular Sciences 2013 14 1802 1821
28. Bharadwaj R., Vidya A., Dewan B., Pal A., An in vitro study to evaluate the synergistic activity of norfloxacin and metronidazole. Indian Journal of Pharmacology 2003 35 4 220 226 2-s2.0-0042024879 (Pubitemid 36998724)
29. Drusano G. L., Bonomo R. A., Bahniuk N., Bulitta J. B., VanScoy B., DeFiglio H., Fikes S., Brown D., Drawz S. M., Kulawy R., Louie A., Resistance emergence mechanism and mechanism of resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 2012 56 1 231 242 2-s2.0-84455192457 10.1128/AAC.05252-11
30. Bassolé I. H. N., Juliani H. R., Essential oils in combination and their antimicrobial properties. Molecules 2012 17 4 3989 4006 2-s2.0-84860254342 10.3390/molecules17043989
31. Sopirala M. M., Mangino J. E., Gebreyes W. A., Biller B., Bannerman T., Balada-Llasat J.-M., Pancholi P., Synergy testing by etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 2010 54 11 4678 4683 2-s2.0-78049319832 10.1128/AAC.00497-10
32. Xiong Y.-Q., Yeaman M. R., Bayer A. S., Linezolid: a new antibiotic. Drugs of Today 2000 36 9 631 639 2-s2.0-0033784563
33. Zhang Y., Chen F., Sun E., Ma R., Qu C., Ma L., In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii. Experimental & Therapeutic Medicine 2013 5 1737 1739
34. Grégoire N., Raherison S., Grignon C., Comets E., Marliat M., Ploy M.-C., Couet W., Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 2010 54 6 2379 2384 2-s2.0-77952597327 10.1128/AAC.01478-08
35. Satoskar R. S., Bhandarkar S. D., Rege N. N., Satoskar R. S., Chapter 49: antimicrobials-combinations. Pharmacology and Pharmacotherapeutics 2009 21st Mumbai, India Popular Prakashan
36. Basri D. F., Jaffar N., Zin N. M., Santhana R., Electron microscope study of gall extract from Quercus infectoria in combination with vancomycin against MRSA using post antibiotic effect determination. International Journal of Pharmacology 2013 9 150 156
37. Hsieh M. H., Yu C. M., Yu V. L., Chow J. W., Synergy assessed by checkerboard. A critical analysis. Diagnostic Microbiology and Infectious Disease 1993 16 4 343 349 2-s2.0-0027263209 10.1016/0732-8893(93)90087-N (Pubitemid 23146839)
38. Steenbergen J. N., Mohr J. F., Thorne G. M., Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. Journal of Antimicrobial Chemotherapy 2009 64 6 1130 1138 2-s2.0-76249093449 10.1093/jac/dkp346
39. Balaji V., Jeremiah S. S., Baliga P. R., Polymyxins: antimicrobial susceptibility concerns and therapeutic options. Indian Journal of Medical Microbiology 2011 29 3 230 242 2-s2.0-80052615920 10.4103/0255-0857.83905
40. Kastoris A. C., Rafailidis P. I., Vouloumanou E. K., Gkegkes I. D., Falagas M. E., Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. European Journal of Clinical Pharmacology 2010 66 4 359 368 2-s2.0-77953942516 10.1007/s00228-010-0794-5
41. Jing W. U., Tian-tong J., Jian-rong S., Li L., Antimicrobial activity of linezolid combined with minocycline against vancomycin-resistant Enterococci. Chinese Medical Journal 2013 126 14 2670 2675
42. Jacqueline C., Caillon J., Le Mabecque V., Miègeville A.-F., Donnio P.-Y., Bugnon D., Potel G., In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Journal of Antimicrobial Chemotherapy 2003 51 4 857 864 2-s2.0-0037392688 10.1093/jac/dkg160 (Pubitemid 36503419)
43. Micek S. T., Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clinical Infectious Diseases 2007 45 3 S184 S190 2-s2.0-34548472399 10.1086/519471 (Pubitemid 47378905)
44. Campos M. A., Morey P., Bengoechea J. A., Quinolones sensitize gram-negative bacteria to antimicrobial peptides. Antimicrobial Agents and Chemotherapy 2006 50 7 2361 2367 2-s2.0-33745597122 10.1128/AAC.01437-05 (Pubitemid 43993173)
45. Tonari K., Mitsui K., Yonemoto K., Structure and antibacterial activity of cinnamic acid related compounds. Journal of Oleo Science 2002 5 1 271 273
46. Hemaiswarya S., Doble M., Synergistic interaction of phenylpropanoids with antibiotics against bacteria. Journal of Medical Microbiology 2010 59 12 1469 1476 2-s2.0-78649405752 10.1099/jmm.0.022426-0
47. Ofokansi K. C., Attama A. A., Uzor P. F., Ovri M. O., Antibacterial activities of the combined leaf extract of Phyllanthus muellerianus and ciprofloxacin against urogenital isolates of Staphylococcus aureus. Clinical Pharmacology and Biopharmaceutics 2012 1 4 1 5
48. Athamna A., Athamna M., Nura A., Shlyakov E., Bast D. J., Farrell D., Rubinstein E., Is in vitro antibiotic combination more effective than single-drug therapy against anthrax? Antimicrobial Agents and Chemotherapy 2005 49 4 1323 1325 2-s2.0-16244377088 10.1128/AAC.49.4.1323-1325.2005 (Pubitemid 40463355)